Hyosung Chemical Balance Sheet Health
Financial Health criteria checks 1/6
Hyosung Chemical has a total shareholder equity of ₩32.5B and total debt of ₩2,640.6B, which brings its debt-to-equity ratio to 8125.3%. Its total assets and total liabilities are ₩3,210.7B and ₩3,178.2B respectively.
Key information
8,125.3%
Debt to equity ratio
₩2.64t
Debt
Interest coverage ratio | n/a |
Cash | ₩102.68b |
Equity | ₩32.50b |
Total liabilities | ₩3.18t |
Total assets | ₩3.21t |
Recent financial health updates
Recent updates
Here's Why Hyosung Chemical (KRX:298000) Is Weighed Down By Its Debt Load
Apr 07What Percentage Of Hyosung Chemical Corporation (KRX:298000) Shares Do Insiders Own?
Mar 10The Hyosung Chemical (KRX:298000) Share Price Is Up 104% And Shareholders Are Boasting About It
Feb 12Factors Income Investors Should Consider Before Adding Hyosung Chemical Corporation (KRX:298000) To Their Portfolio
Jan 22With A 0.8% Return On Equity, Is Hyosung Chemical Corporation (KRX:298000) A Quality Stock?
Jan 01What You Need To Know About Hyosung Chemical Corporation's (KRX:298000) Investor Composition
Dec 09We're Not Counting On Hyosung Chemical (KRX:298000) To Sustain Its Statutory Profitability
Nov 19Financial Position Analysis
Short Term Liabilities: A298000's short term assets (₩812.6B) do not cover its short term liabilities (₩2,818.3B).
Long Term Liabilities: A298000's short term assets (₩812.6B) exceed its long term liabilities (₩359.9B).
Debt to Equity History and Analysis
Debt Level: A298000's net debt to equity ratio (7809.3%) is considered high.
Reducing Debt: A298000's debt to equity ratio has increased from 274.8% to 8125.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A298000 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if A298000 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 04:04 |
End of Day Share Price | 2025/01/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hyosung Chemical Corporation is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hee Cheol Lee | DAOL Investment & Securities Co., Ltd. |
null null | DBS Bank Ltd |
Woo-Je Chun | Hanwha Investment & Securities Co., Ltd. |